pharmaphorum

APRIL 28, 2022

Despite the inherent difficulties, major pharma companies do take aim at rare diseases, usually with dedicated units focusing on clusters of rare diseases that afflict the same part of the body. How big pharma tackles rare diseases. It’s a different business model, if you will,” Miquel said. “So So that is the trick.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

pharmaphorum

JANUARY 6, 2021

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. It’s a dynamic reflection of our purpose. pic.twitter.com/vNqCgWus4w.

DNA 116

DNA Branding Vaccination Vaccine 116

Delveinsight

JANUARY 8, 2021

HDV is nothing but a defective RNA virus, a satellite of the helper Hepatitis B virus (HBV) that needs the HBsAg of the hepatitis B virus (HBV) for virion assembly, release, and transmission. Recently, the Europe commission approved Bulevirtide (brand name Hepcludex) for the treatment of Hepatitis D after decades of research and trials.

Marketing 52

Marketing RNA Development Pharma Companies 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Because right now, I’m going to share something BRAND-NEW, backed by mountains of scientific research which will help to treat your pain. Stimulates DNA and RNA synthesis. It’s all about the bottom line, at any cost.

Production 52

Production Pharmacy Doctors Doctor 52